EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties

Héléna Boutzen, Alex Murison, Alexa Oriecuia, Suraj Bansal, Christopher Arlidge, Jean C Y Wang, Mathieu Lupien, Kerstin B Kaufmann iD, John E Dick iD

Leukemia · 2024-10 · 38 (10) · 2090-2101

DOI: 10.1038/s41375-024-02358-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia, online erschienen am 21.08.2024. Verfasst von Héléna Boutzen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 0A3, Canada. helena.boutzen@gmail.com. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Leukemia, Myeloid, Acute, Epigenesis, Genetic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Princess Margaret Cancer Foundation (PMCF), Canadian Cancer Society Research Institute (Société Canadienne du Cancer), Leukemia and Lymphoma Society of Canada (Leukemia & Lymphoma Society of Canada).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The leukemia stem cell (LSC) compartment is a complex reservoir fueling disease progression in acute myeloid leukemia (AML). The existence of heterogeneity within this compartment is well documented but prior studies have focused on genetic heterogeneity without being able to address functional heterogeneity. Understanding this heterogeneity is critical for the informed design of therapies targeting LSC, but has been hampered by LSC scarcity and the lack of reliable cell surface markers for viable LSC isolation. To overcome these challenges, we turned to the patient-derived OCI-AML22 cell model. This model includes functionally, transcriptionally and epigenetically characterized LSC broadly representative of LSC found in primary AML samples. Focusing on the pool of LSC, we used an integrated approach combining xenograft assays with single-cell analysis to identify two LSC subtypes with distinct transcriptional, epigenetic and functional properties. These LSC subtypes differed in depth of quiescence, differentiation potential, repopulation capacity, sensitivity to chemotherapy and could be isolated based on CD112 expression. A majority of AML patient samples had transcriptional signatures reflective of either LSC subtype, and some even showed coexistence within an individual sample. This work provides a framework for investigating the LSC compartment and designing combinatorial therapeutic strategies in AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsLeukemia, Myeloid, AcuteEpigenesis, GeneticHumansAnimalsMiceTranscription, GeneticCell DifferentiationCell Line, TumorSingle-Cell Analysis

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 0A3, Canada. helena.boutzen@gmail.com.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 0A3, Canada.
  • Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, ON, Canada.
  • Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, ON, M5S 1A4, Canada.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 0A3, Canada. kerstin.kaufmann@uhn.ca.

ORCID-Profile: Kerstin B Kaufmann, John E Dick

Förderung

  • Princess Margaret Cancer Foundation (PMCF)
  • Canadian Cancer Society Research Institute (Société Canadienne du Cancer)
  • Leukemia and Lymphoma Society of Canada (Leukemia & Lymphoma Society of Canada)

Zitieren

APA

Boutzen, H., Murison, A., Oriecuia, A., Bansal, S., Arlidge, C., Wang, J. C. Y., Lupien, M., Kaufmann, K. B., & Dick, J. E. (2024). Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties. Leukemia, 38(10), 2090-2101. https://doi.org/10.1038/s41375-024-02358-9

Vancouver

Boutzen H, Murison A, Oriecuia A, Bansal S, Arlidge C, Wang JCY, et al. Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties. Leukemia. 2024;38(10):2090-2101. doi:10.1038/s41375-024-02358-9

BibTeX
@article{Boutzen2024,
  author = {Boutzen, Héléna and Murison, Alex and Oriecuia, Alexa and Bansal, Suraj and Arlidge, Christopher and Wang, Jean C Y and Lupien, Mathieu and Kaufmann, Kerstin B and Dick, John E},
  title = {Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties},
  journal = {Leukemia},
  year = {2024},
  volume = {38},
  number = {10},
  pages = {2090--2101},
  doi = {10.1038/s41375-024-02358-9}
}
Kostenlos starten →